Bank Of New York Mellon Corp Roivant Sciences Ltd. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.36 - $7.99 $447,578 - $1.06 Million	133,208 New	133,208 $1.06 Million
Q3 2022 Nov 14, 2022	BUY	$0.51 - $4.84 $2,291 - $21,746	4,493 Added 3.92%	119,063 $384,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $4.84 $189,101 - $325,712	67,296 Added 142.35%	114,570 $466,000
Q1 2022 May 11, 2022	BUY	$4.74 - $9.91 $20,547 - $42,959	4,335 Added 10.1%	47,274 $233,000
Q4 2021 Feb 11, 2022	BUY	$5.86 - $13.52 $251,622 - $580,535	42,939 New	42,939 $433,000

308

496M

989K

1.15M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.49B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.